Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease

Clinical Therapeutics

Volumn 22, Issue 4, 2000, Pages 452-469

  Balkrishnan, Rajesh ^a,c   Christensen, Dale B ^b  

^a Section on Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Elderly; Inhaled corticosteroids; Managed competition; Outcomes; Patient compliance

Indexed keywords

CORTICOSTEROID;

AGED; ARTICLE; ASTHMA; COMORBIDITY; CORTICOSTEROID THERAPY; FEMALE; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HEALTH SERVICE; HOSPITALIZATION; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

EID: 0034035549     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)89013-X     Document Type: Article

References (31)

1. 1. Mannino DM, Homa DM, Petrowski CA, et al. Surveillance for asthma - United States, 1960-1995. MMWR CDC Surveill Summ. 1998;47:1-27.
2. 2. Broder I, Higgins MW, Matthews KP, Keler JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, MI. 3. Second survey of community. J Allergy Clin Immunol. 1974;53: 127-138.
3. 3. Dodge R, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis. 1980;122:567-575.
4. 4. Tiep BL. Disease management of COPD with pulmonary rehabilitation. Chest. 1997; 112:1630-1656.
5. 5. Burr ML, Charles TJ, Roy K, Seaton A. Asthma in the elderly: An epidemiological survey. Br Med J. 1979;1:1041-1044.
6. 6. Horsly JR, Sterling IJN, Walters WE. Respiratory symptoms among elderly people in the New Forest area assessed by a postal questionnaire. Age Ageing. 1991;20: 325-331.
7. 7. Luce PJ. Asthma in the elderly. Br J Hosp Med. 1996;55:118-120.
8. 8. Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: The Johns Hopkins University Press; 1979:1-7.
9. 9. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther. 1998; 20:764-771.
10. 10. Smith DH, Malone DC, Lawson KA, et al. A national estimate of economic costs of asthma. Am J Respir Crit Care Med. 1997;156:787-793.
11. 11. Schmeir JK, Leidy NK. The complexity of treatment adherence in adults with asthma: Challenges and opportunities. J Asthma. 1998;6:455-472.
12. 12. National Heart, Lung, and Blood Institute. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Heart, Lung, and Blood Institute; 1997.
13. 13. Bai TR. Glucocorticosteroid treatment of asthma. Can Fam Phys. 1995;41: 1921-1927.
14. 14. van Schayk CP, van Grunsven PM, Dekhuijzen PNR. Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur Respir J. 1996;9:1969-1972.
15. 15. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis. Am J Emerg Med. 1992;10:301-310.
16. 16. Hatoum HT, Schumock GT, Kendzierski DL. Meta-analysis of controlled trials of drug therapy in mild chronic asthma: The role of inhaled corticosteroids. Ann Pharmacother. 1994;28:1285-1289.
17. 17. Choo PW, Rand CS, Invi TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
18. 18. Steiner JF, Koepsell TD, Fihn SD, Invi TS. A general method of compliance assessment using centralized pharmacy records. Med Care. 1988;26:814-823.
19. 19. International Classification of Diseases, Ninth Revision, Clinical Modification. Hyattsville, Md: US Department of Health and Human Services, Public Health Service; 1998.
20. 20. Erzen D, Roos LL, Manfreda J, Athonisen NR. Changes in asthma severity in Manitoba. Chest. 1995;108:16-23.
21. 21. Charlson ME, Pompei P, Ales KL, MacKenzie R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-383.
22. 22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
23. 23. Greene WH. Econometric Analysis. 3rd ed. Englewood Cliffs, NJ: Prentice-Hall; 1997.
24. 24. Stata™ Statistical Software. Release 5.0, User Manual. College Station, Tex: Stata Statistical Software; 1997.
25. 25. Halverson R, Palmquist R. The interpretation of dummy variables in semilogarithmic equations. Am Econ Rev. 1980;70: 474-475.
26. 26. Kennedy P. Estimation with correctly interpreted dummy variables in semilogarithmic equations. Am Econ Rev. 1981; 71:801. Letter.
27. 27. US Bureau of Labor Statistics Consumer Price Index Summary. Available at http:// stats.bls.gov. Accessed July 15, 1999.
28. 28. Cook R, Weisberg S. An Introduction to Regression Graphics. New York: John Wiley & Sons; 1994.
29. 29. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817-838.
30. 30. International Consensus Report on Diagnosis and Treatment of Asthma. Eur Respir J. 1992;5:601-641.
31. 31. Adams S, Pill R, Jones A. Medication, chronic illness and identity: The perspective of people with asthma. Soc Sci Med. 1997;45:189-201.